We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

By HospiMedica International staff writers
Posted on 17 Sep 2026

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. More...

Emergency departments often use computed tomography angiography to identify these blockages, but contrast requirements and workflow constraints can delay imaging, potentially leaving large vessel occlusions undetected within critical treatment windows. To support earlier detection, researchers have validated an artificial intelligence tool that identifies large vessel occlusion on standard non-contrast CT.

The non-contrast CT-based large vessel occlusion detection algorithm from JLK was validated by investigators at Korea University Guro Hospital, Korea University College of Medicine, with collaborators at Seoul National University Bundang Hospital. The system analyzes routine head scans to flag suspected large vessel occlusion without the need for contrast imaging. Findings were published in the Journal of NeuroInterventional Surgery.

The team evaluated diagnostic performance using a multinational cohort of 963 patients, including 723 from Korea and 240 from the United States. Standalone area under the receiver operating characteristic curve (AUC) reached 0.963 in the Korean cohort and 0.899 in the U.S. cohort. High diagnostic performance persisted across different countries and various computed tomography scanners.

In a separate reader study involving eight clinicians, including specialists and residents, AI support improved interpretation of non-contrast CT. Reader accuracy increased from an AUC of 0.718 without support to 0.852 with support. Sensitivity rose from 46.6% to 63.7%, and specificity increased from 91.9% to 94.9%, equating to one additional large vessel occlusion identified for every 18 scans reviewed with assistance. No clear evidence of automation bias was observed.

Because endovascular thrombectomy is crucial to reopen blocked vessels, early recognition of large vessel occlusion directly influences prognosis. The results indicate that artificial intelligence can serve as a safety net to complement clinician judgment during time-sensitive stroke care. The approach addresses delays or barriers to computed tomography angiography by leveraging the most accessible imaging available in the emergency setting.

"This is clinically very significant: We can now rapidly and accurately identify severe stroke patients in the time-sensitive emergency room using only the most accessible equipment: non-contrast CT," said Chi Kyung Kim, Department of Neurology, Korea University Guro Hospital.

"With the help of AI, inexperienced medical staff or resident doctors can achieve diagnostic accuracy close to that of skilled specialists. This will significantly raise the standard of care at local hospitals and during nighttime emergencies," said Jun Sun-woo, Department of Radiology, Seoul National University Bundang Hospital.

Related Links
Korea University College of Medicine
Korea University Guro Hospital


Gold Member
12-Channel ECG
CM1200B
Gold Member
Blood Gas Analyzer
i-Check200
Hybrid Arch Device
Neo EDE
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Visual Abstract (Andrea Farolfi et al., Journal of Nuclear Medicine, 2026. DOI: 10.2967/jnumed.126.272108)

PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI

Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.